Arficus COVTREAT

COVTREAT Provides Diagnosing of COVID-19 in less than 53 seconds through Artificial Intellgence, now upgraded for diagnosing of TB, Pneumonia, Breast Cancer

  • Stage $500K in TTM Revenue
  • Industry Healthcare Services
  • Location Bengaluru, Karnataka, India
  • Currency INR
  • Founded December 2019
  • Employees 17
  • Incorporation Type C-corp
  • Website arficus.com

Company Summary

Arficus COVTREAT provides AI based Covid-19 diagnosing in only 53 seconds, to make it a long sustainable solution it has now been upgraded for diagnosing of breast cancer and TB.
Business Model
B2B include Hospitals,Airports,Railways Stations, Bus stations, Hotels and white
labelling with Healthtech Firms like Philips, Lancet, GE
etc.
- B2C Model includes direct testing via Mobile vans, Mobile labs, Quarantine centres testing, Private testing.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free